Hepatocellular carcinoma outcomes based on indicated treatment strategy

Rose, Amy T.; Rose, D. Michael; Pinson, C. Wright; Wright, J. Kelly; Blair, Taylor; Blanke, Charles; Delbeke, Dominique; Debelak, J.P.; Chapman, William C.
December 1998
American Surgeon;Dec1998, Vol. 64 Issue 12, p1128
Academic Journal
Determines individual outcome of treatment strategies on hepatocellular carcinoma (HCC) in Nashville, Tennessee. Types of treatment strategies for HCC; Survival rates of patients according to type of treatment strategy; Differences in survival rate of patients at different stages of HCC; Predisposing factors and complications of HCC.


Related Articles

  • Predictive Factor of Local Recurrence after Balloon-Occluded TACE with Miriplatin (MPT) in Hepatocellular Carcinoma. Ishikawa, Toru; Abe, Satoshi; Inoue, Ryousuke; Sugano, Tomoyuki; Watanabe, Yuhsuke; Iwanaga, Akito; Seki, Keiichi; Honma, Terasu; Nemoto, Takeo; Takeda, Keiko; Yoshida, Toshiaki // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    Background: Miriplatin (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular carcinoma (HCC). However, rapid washout has been reported in some cases. Therefore, various methods of administration with MPT have been attempted to increase its...

  • Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis. Chaiteerakij, Roongruedee; Chattieng, Piyanat; Choi, Jonggi; Pinchareon, Nutcha; Thanapirom, Kessirin; Geratikornsupuk, Nopavut // Annals of Hepatology: Official Journal of the Mexican Associatio;May/Jun2017, Vol. 16 Issue 3, p421 

    Background. Evidence supporting benefit of hepatocellular carcinoma (HCC) surveillance in reducing mortality is not well-established. The effect of HCC surveillance in reducing mortality was assessed by an inverse probability of treatment weighting (IPTW)- based analysis controlled for inherent...

  • Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma. Lee, Sangheun; Kim, Beom Kyung; Kim, Seung Up; Park, Yehyun; Chang, Sooyun; Park, Jun Yong; Kim, Do Young; Ahn, Sang Hoon; Chon, Chae Yoon; Han, Kwang-Hyub // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Background:Although sorafenib is accepted as the standard of care in advanced hepatocellular carcinoma (HCC), its therapeutic benefit is marginal. Here, we aimed to compare the efficacy and safety of sorafenib monotherapy (S-M) and sorafenib-based loco-regional treatments (S-LRTs) in advanced...

  • Single Nucleotide Polymorphisms of MicroRNA Processing Machinery Genes and Outcome of Hepatocellular Carcinoma. Liu, Shuang; An, Jie; Lin, Jianhong; Liu, Yanli; Bao, Lidao; Zhang, Wen; Zhao, Jian-Jun // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    MicroRNA (miRNA)-related single nucleotide polymorphisms (miR-SNPs) can affect cancer development, treatment efficacy and patients prognosis. We examined 6 miR-SNPs in miRNA processing machinery genes including exportin 5 (XPO5) (rs11077), Ran-GTPase (RAN) (rs14035), Dicer (rs3742330),...

  • Determinants of Long-Term Outcome in Patients Undergoing Simultaneous Resection of Synchronous Colorectal Liver Metastases. Lin, Qi; Ye, Qinghai; Zhu, Dexiang; Wei, Ye; Ren, Li; Ye, Lechi; Feng, Qingyang; Xu, Pingping; Zheng, Peng; Lv, Minzhi; Fan, Jia; Xu, Jianmin // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Background: It remains unclear which patients can benefit from simultaneous resection of synchronous colorectal liver metastases (SCRLMs). This study aimed to examine the prognostic value of patient- and tumor-related factors in predicting long-term outcomes of patients undergoing simultaneous...

  • OPN and αvβ3 Expression are Predictors of Disease Severity and Worse Prognosis in Hepatocellular Carcinoma. Jin, Yi; Chen, Jian-ning; Feng, Zhi-ying; Zhang, Zhi-gang; Fan, Wen-zhe; Wang, Yu; Li, Jia-ping // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Expressions of OPN and αvβ3 are associated with a poor prognosis in many malignancies. However, their relationship in hepatocellular carcinoma remains unclear. We systematically collected hepatocellular carcinoma tissue samples from 305 patients over 3 years, and analyzed the status of OPN...

  • The Singapore Liver Cancer Recurrence (SLICER) Score for Relapse Prediction in Patients with Surgically Resected Hepatocellular Carcinoma. Ang, Soo Fan; Ng, Elizabeth Shu-Hui; Li, Huihua; Ong, Yu-Han; Choo, Su Pin; Ngeow, Joanne; Toh, Han Chong; Lim, Kiat Hon; Yap, Hao Yun; Tan, Chee Kiat; Ooi, London Lucien Peng Jin; Chung, Alexander Yaw Fui; Chow, Pierce Kah Hoe; Foo, Kian Fong; Tan, Min-Han; Cheow, Peng Chung // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Background and Aims: Surgery is the primary curative option in patients with hepatocellular carcinoma (HCC). Current prognostic models for HCC are developed on datasets of primarily patients with advanced cancer, and may be less relevant to resectable HCC. We developed a postoperative nomogram,...

  • Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy. Guo, Zhe; Zhang, Jun; Jiang, Jing-Hang; Li, Le-Qun; Xiang, Bang-De // PLoS ONE;May2015, Vol. 10 Issue 5, p1 

    Background: Whether obesity affects surgical outcomes in patients with hepatocellular carcinoma (HCC) is controversial. Here we retrospectively evaluated the impact of obesity on outcomes in HCC patients after curative hepatectomy. Methods: Patients with Child-Pugh A liver function who...

  • Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis. Fan, Jun-Li; Yang, Yi-Fei; Yuan, Chun-Hui; Chen, Hao; Wang, Fu-Bing // Cellular Physiology & Biochemistry (Karger AG);Sep2015, Vol. 37 Issue 2, p629 

    Background/Aims: The prognostic value of circulating tumor cells (CTC) detected in hepatocellular carcinoma (HCC) patients is currently under debate. We conducted a meta-analysis of available studies to assess its prognostic value for patients diagnosed with HCC. Methods: Medline, Ovid Database,...

  • Circulating Hepatocellular Carcinoma Cells are Characterized by CXCR4 and MMP26. Yu, Chang; Wang, Zhiting; Xu, Xiaomei; Xiang, Wei; Huang, Xiaoying // Cellular Physiology & Biochemistry (Karger AG);Aug2015, Vol. 36 Issue 6, p2393 

    Background/Aims: Primary hepatocellular carcinoma (HCC) is highly invasive, and often results in an early distal metastasis resulting in poor prognosis and therapeutic outcome. Cancer cells disseminating from the tumor and entering circulation are termed circulating tumor cells (CTCs). Although...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics